Limbix
AcquiredDigital therapeutics for adolescent mental health
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2016
- Website
- limbix.com
- Total Funding
- $24.0M
- Last Round
- $15.0M Series ADec 2021
- Rounds
- 2
About
Limbix is a prescription digital therapeutics company focused on adolescent mental health. Founded in 2016 and headquartered in Palo Alto, California, it developed SparkRx — a cognitive behavioral therapy (CBT)-based digital therapeutic program for teens and young adults experiencing symptoms of depression. Limbix pairs clinical expertise with technology, employing clinicians, product designers, researchers, and engineers focused on delivering accessible mental health treatment to young people. The company raised $31 million in a Series A and was acquired by Big Health in July 2023.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Jul 2023
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe
Mehiläinen is a leading Finnish private healthcare company providing medical, health, and special...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Biopharmaceutical services company